Table of Contents
Research & Development
| Genentech Pays US$120 M Upfront for UCB’s Tau-targeting Antibody UCB0107 | Abstract html pdf |
| Michelle Liu |
| Gilead Expands Deal and Triples Tango Targets to 15 | Abstract pdf html |
| Michelle Liu |
Mergers & Acquisitions
| Sanofi Acquires Principia for US$3.68 B | Abstract html pdf |
| Michelle Liu |
| J&J Focuses on Immunology with US$6.5 B Momenta Buyout | Abstract pdf html |
| Michelle Liu |
This work is licensed under a Creative Commons Attribution 3.0 License.